Foundation Medicine Announces 2015 Third Quarter Results and Recent Highlights
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/12/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Foundation Medicine (FMI) PT Lowered to $27 at Leerink Partners Amid Lower Forecast
November 4, 2015 7:49 AM ESTLeerink Partners analyst Dan Leonard lowered his price target on Foundation Medicine (NASDAQ: FMI) to $27.00 (from $36.00) while maintaining a Market Perform rating. The firm noted clinical volume was light and forecasts were reduced meaningfully.
Leonard commented, "FMI exceeded Street revenue expectations in the... More
Foundation Medicine (FMI) Misses Q3 EPS by 4c, Offers FY15 Guidance
November 3, 2015 4:01 PM ESTFoundation Medicine (NASDAQ: FMI) reported Q3 EPS of ($0.60), $0.04 worse than the analyst estimate of ($0.56). Revenue for the quarter came in at $25.4 million versus the consensus estimate of $24.04 million.
Foundation Medicine sees FY2015 revenue of $85-95 million, versus the consensus of $92.10 million.
For earnings... More
